166 related articles for article (PubMed ID: 15151374)
1. Angiotensin receptors blockers are preferred to angiotensin-converting inhibitors [corrected].
Feldman L; Weissgarten J
Isr Med Assoc J; 2004 May; 6(5):299-300. PubMed ID: 15151374
[No Abstract] [Full Text] [Related]
2. Angiotensin receptor blockers do not have an advantage over angiotensin-converting inhibitors [corrected].
Harman-Boehm I
Isr Med Assoc J; 2004 May; 6(5):296-8. PubMed ID: 15151373
[No Abstract] [Full Text] [Related]
3. Renin angiotensin system blockade and nephropathy: why is it being called into question, and should it be?
Hollenberg NK; Epstein M
Clin J Am Soc Nephrol; 2006 Sep; 1(5):1046-8. PubMed ID: 17699325
[No Abstract] [Full Text] [Related]
4. [RAS blockade in diabetic nephropathy. "Early intervention can dramatically decrease loss of function].
Ritz E
MMW Fortschr Med; 2004 Sep; 146(38):12. PubMed ID: 15532423
[No Abstract] [Full Text] [Related]
5. Inhibition of the renin-angiotensin system, with particular reference to dual blockade treatment.
Andersen NH; Mogensen CE
J Renin Angiotensin Aldosterone Syst; 2001 Sep; 2(3):146-52. PubMed ID: 11881115
[No Abstract] [Full Text] [Related]
6. Optimal inhibition of renin angiotensin system to salvage 'at risk' diabetic kidneys--emerging Indian evidence.
Shah SN; Bansode BR; Kamath SA
J Assoc Physicians India; 2004 Mar; 52():183-6. PubMed ID: 15636305
[No Abstract] [Full Text] [Related]
7. [Multilevel blockade of the renin-angiotensin-aldosterone system in the treatment of diabetic nephropathy].
Fronczyk A; Majkowska L
Przegl Lek; 2007; 64(2):81-5. PubMed ID: 17892038
[TBL] [Abstract][Full Text] [Related]
8. [Dual blockade of the renin-angiotensin system].
Andersen NH; Mogensen CE
Ugeskr Laeger; 2004 Oct; 166(43):3799-803. PubMed ID: 15544108
[No Abstract] [Full Text] [Related]
9. Treating diabetic nephropathy: unfinished success is not failure.
Lewis J
Clin J Am Soc Nephrol; 2007 May; 2(3):407-9. PubMed ID: 17699442
[No Abstract] [Full Text] [Related]
10. Dual blockade of the renin-angiotensin system in diabetic nephropathy.
Wade VL; Gleason BL
Ann Pharmacother; 2004; 38(7-8):1278-82. PubMed ID: 15187210
[TBL] [Abstract][Full Text] [Related]
11. [Renoprotection and blockade of the renin-angiotensin system: What shall we believe?].
Kamper AL; Feldt-Rasmussen B; Strandgaard S
Ugeskr Laeger; 2006 Apr; 168(15):1563. PubMed ID: 16640988
[No Abstract] [Full Text] [Related]
12. Renoprotection by blocking the RAAS in diabetic nephropathy--fact or fiction?
Rossing P; Parving HH; de Zeeuw D
Nephrol Dial Transplant; 2006 Sep; 21(9):2354-7; discussion 2357-8. PubMed ID: 16928724
[No Abstract] [Full Text] [Related]
13. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers for prevention and treatment of nephropathy associated with type 2 diabetes mellitus.
Hughes DB; Britton ML
Pharmacotherapy; 2005 Nov; 25(11):1602-20. PubMed ID: 16232022
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what to do if the serum creatinine and/or serum potassium concentration rises.
Palmer BF
Nephrol Dial Transplant; 2003 Oct; 18(10):1973-5. PubMed ID: 13679467
[No Abstract] [Full Text] [Related]
15. Angiotensin II receptor blockade in diabetic nephropathy.
Andersen S
Dan Med Bull; 2004 Aug; 51(3):274-94. PubMed ID: 16009059
[No Abstract] [Full Text] [Related]
16. Maximizing inhibition of the renin-angiotensin system with high doses of converting enzyme inhibitors or angiotensin receptor blockers.
Berl T
Nephrol Dial Transplant; 2008 Aug; 23(8):2443-7. PubMed ID: 18467376
[No Abstract] [Full Text] [Related]
17. Renoprotective effects of renin-angiotensin-system inhibitors.
Parving HH; Rossing P
Lancet; 2006 Mar; 367(9514):898-9; author reply 900-2. PubMed ID: 16546532
[No Abstract] [Full Text] [Related]
18. The renin-angiotensin system and diabetic nephropathy.
Gurley SB; Coffman TM
Semin Nephrol; 2007 Mar; 27(2):144-52. PubMed ID: 17418683
[TBL] [Abstract][Full Text] [Related]
19. ACE inhibitors versus angiotensin receptor blockers in diabetic nephropathy: is there a winner?
Lewis EJ; Lewis JB
J Am Soc Nephrol; 2004 May; 15(5):1358-60. PubMed ID: 15100380
[No Abstract] [Full Text] [Related]
20. [Renin-angiotensin system].
Ito S
Nihon Jinzo Gakkai Shi; 2007; Suppl 50th Ann():103-6. PubMed ID: 17899835
[No Abstract] [Full Text] [Related]
[Next] [New Search]
